CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 471 filers reported holding CRISPR THERAPEUTICS AG in Q3 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $333,000 | +22.4% | 5,101 | +14.2% | 0.01% | +27.3% |
Q2 2022 | $272,000 | +15.7% | 4,468 | 0.0% | 0.01% | +22.2% |
Q1 2022 | $235,000 | +9.8% | 4,468 | +57.9% | 0.01% | +28.6% |
Q4 2021 | $214,000 | -97.3% | 2,830 | -95.9% | 0.01% | -97.7% |
Q3 2021 | $7,790,000 | +1847.5% | 69,597 | +2715.4% | 0.31% | +1812.5% |
Q2 2021 | $400,000 | +63.9% | 2,472 | +23.6% | 0.02% | +45.5% |
Q1 2021 | $244,000 | -20.3% | 2,000 | 0.0% | 0.01% | -21.4% |
Q4 2020 | $306,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |